BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26776392)

  • 1. [Negative symptoms in schizophrenia: new pharmacological approaches].
    Lodovighi MA; Palomba A; Belzeaux R; Adida M; Azorin JM
    Encephale; 2015 Dec; 41(6 Suppl 1):6S41-9. PubMed ID: 26776392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacology of the negative symptoms: current status and prospects for progress.
    Davis MC; Horan WP; Marder SR
    Eur Neuropsychopharmacol; 2014 May; 24(5):788-99. PubMed ID: 24252823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of negative symptoms of schizophrenia: An update.
    Tsapakis EM; Dimopoulou T; Tarazi FI
    Pharmacol Ther; 2015 Sep; 153():135-47. PubMed ID: 26116809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Negative symptoms: which antipsychotics?].
    Maurel M; Belzeaux R; Adida M; Azorin JM
    Encephale; 2015 Dec; 41(6 Suppl 1):6S32-5. PubMed ID: 26776390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Negative symptoms of schizophrenia: from electrophysiology to electrotherapy].
    Micoulaud Franchi JA; Quiles C; Belzeaux R; Adida M; Azorin JM
    Encephale; 2015 Dec; 41(6 Suppl 1):6S50-6. PubMed ID: 26776393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistant schizophrenia: definitions and procedures].
    Delaunay V
    Encephale; 2006 Oct; 32(5 Pt 4):S925-6. PubMed ID: 17119509
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment-resistant schizophrenia - biological treatments].
    Hasan A; Wobrock T
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):464-71; quiz 472. PubMed ID: 23939560
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of antidepressants in the treatment of negative symptoms of schizophrenia].
    Palomba A; Lodovighi MA; Belzeaux R; Adida M; Azorin JM
    Encephale; 2015 Dec; 41(6 Suppl 1):6S36-40. PubMed ID: 26776391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Negative symptoms in schizophrenia: psychotherapeutic approaches].
    Azorin JM; Adida M; Belzeaux R; Pringuey D; Micoulaud Franchi JA; Simon N; Cermolacce M; Kaladjian A; Fakra E
    Encephale; 2015 Dec; 41(6 Suppl 1):6S57-60. PubMed ID: 26776394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis.
    Dlabac-de Lange JJ; Knegtering R; Aleman A
    J Clin Psychiatry; 2010 Apr; 71(4):411-8. PubMed ID: 20361909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study.
    Prikryl R; Kasparek T; Skotakova S; Ustohal L; Kucerova H; Ceskova E
    Schizophr Res; 2007 Sep; 95(1-3):151-7. PubMed ID: 17689931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing treatments for impaired cognition in schizophrenia.
    Minzenberg MJ; Carter CS
    Trends Cogn Sci; 2012 Jan; 16(1):35-42. PubMed ID: 22178120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of negative symptoms: pharmacological and methodological issues.
    Carpenter WT
    Br J Psychiatry Suppl; 1996 May; (29):17-22. PubMed ID: 8733819
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent psychotropic medication has no negative influence on the outcome of electroconvulsive therapy.
    O'Brien PD; Berrios GE
    Encephale; 1993; 19(4):347-9. PubMed ID: 7903929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-invasive brain stimulation for treatment of schizophrenic psychoses].
    Hasan A; Wobrock T; Palm U; Strube W; Padberg F; Falkai P; Fallgatter A; Plewnia C
    Nervenarzt; 2015 Dec; 86(12):1481-91. PubMed ID: 26341690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of antipsychotics with electroconvulsive therapy in treatment-resistant schizophrenia patients with dominant negative symptoms: a pilot study of effectiveness.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Neuropsychobiology; 2014; 70(3):158-64. PubMed ID: 25358377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of negative symptoms in schizophrenia.
    Möller HJ; Czobor P
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):567-78. PubMed ID: 25895634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders.
    Slotema CW; Blom JD; Hoek HW; Sommer IE
    J Clin Psychiatry; 2010 Jul; 71(7):873-84. PubMed ID: 20361902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study.
    Mogg A; Purvis R; Eranti S; Contell F; Taylor JP; Nicholson T; Brown RG; McLoughlin DM
    Schizophr Res; 2007 Jul; 93(1-3):221-8. PubMed ID: 17478080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.